Docetaxel treatment of HT-29 colon carcinoma cells reinforces the adhesion and immunocytotoxicity of peripheral blood lymphocytes in vitro. (Q41050130)
Jump to navigation
Jump to search
scientific article published on April 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Docetaxel treatment of HT-29 colon carcinoma cells reinforces the adhesion and immunocytotoxicity of peripheral blood lymphocytes in vitro. |
scientific article published on April 1998 |
Statements
Docetaxel treatment of HT-29 colon carcinoma cells reinforces the adhesion and immunocytotoxicity of peripheral blood lymphocytes in vitro (English)
E Grünberg
K Eckert